Results 211 to 220 of about 33,379 (274)

Dual-Targeting, Hybrid Antifungal Agents Targeting Candida albicans-An Overview. [PDF]

Chem Biol Drug Des
Pal S, Pusti S, Ansari IH, Pradhan S, Bhattacharya H, Das S.   +5 more
europepmc   +1 more source

Treatment and outcome of chronic disseminated candidiasis in the era of antifungal prophylaxis: a retrospective multicentre cohort of 111 patients. [PDF]

EClinicalMedicine
Reinhold I, Ramirez-Sanchez IC, Chen PY, Chen YC, Dhariwal A, Lambourne J, Agrawal S, Bastida M, Gudiol C, Alfandari S, Di Pilla A, Khostelidi S, Aguilar-Zapata D, Barac A, Cipriano A, Ehrlich S, Grothe J, Illarramendi J, Jennrich S, Khedr R, Leotta D, Méndez GA, Nacov JA, Nagao M, Saydam G, Schwartz S, Steinmann J, Arn K, Enoch DA, Föhring D, Joean O, Koehler P, Krause R, Maertens J, Marchesi F, Onyeaghala C, Stone N, Vanbiervliet Y, Wolfensberger N, Haensel L, Hurraß J, Panse J, Sal E, Stemler J, Bové DS, Sprute R, Minero MV, Vena A, Pagano L, Cornely OA, Seidel D, FungiScope® Working Group of the European Confederation of Medical Mycology (ECMM) and the International Society for Human and Animal Mycology (ISHAM);, Fungal Infections Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG) and the ESCMID Study Group for Infections in Compromised Hosts (ESGICH).   +52 more
europepmc   +1 more source

Recent Outbreaks, Resistance Trends, and Control Measures in <i>Candida auris</i> and <i>Candida glabrata</i> Infections. [PDF]

J Fungi (Basel)
Raeisi S, Madhavan P, Adisuri DS.
europepmc   +1 more source

Synthesis of azole-fused thiazinethiones using a carbon disulfide surrogate <i>via</i> C-N/C-S tandem coupling and cyclization under reusable magnetic Cu-MOF-74 catalysis. [PDF]

RSC Adv
Hoang TH, Tran QN, Nguyen XT, Vo DMH, Dao PDQ.   +4 more
europepmc   +1 more source

Design, synthesis, and biological evaluation of azole antifungals against multidrug-resistant <i>Candida auris</i>. [PDF]

RSC Med Chem
Chen Y, Li Y, Nahar KS, Hind CK, Sutton JM, Rahman KM.   +5 more
europepmc   +1 more source

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates [PDF]

Clinical Microbiology and Infection, 2019
BACKGROUND The emergence of azole-resistant Aspergillus fumigatus isolates is a matter of significant concern in Europe, with countries reporting resistance rates (which can be as high as 30%) in hospitalized patients.
Mihai Mareș, Maiken C Arendrup, Jesus Guinea   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Synthesis of New Azolyl Azoles and Azinyl Azoles.

ChemInform, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
Balkis Al-Saleh, Morsy Ahmed El-Apasery, Mohamed Hilmy Elnagdi   +2 more
openaire   +1 more source

Azoles and AIDS

The Journal of Infectious Diseases, 1990
The treatment of opportunistic infections in AIDS patients is changing rapidly as new drugs become available and new studies of old drugs are completed. I have tried to use the AIDS commentaries to keep up with these advances. Since fluconazole has just recently been approved by the US Food and Drug Administration, I asked Dr. Robert A.
openaire   +2 more sources

Sulfonyl Azoles in the Synthesis of 3-Functionalized Azole Derivatives

The Chemical Record, 2016
Sulfonyl indoles, as well as related azolyl derivatives, have been recently introduced in synthesis as stable precursors of reactive indolenine intermediates. This personal account reports on the discovery of sulfonyl azoles and their practical utilization in many synthetic processes for the preparation of functionalized 3-substituted indoles ...
PALMIERI, Alessandro, PETRINI, Marino
openaire   +2 more sources

Update on Azole Antifungals

Seminars in Respiratory and Critical Care Medicine, 2008
This is a comprehensive, clinically oriented review of the four commercially available triazoles: fluconazole, itraconazole, voriconazole, and posaconazole. Emphasis is placed in pharmacology, drug interactions, adverse events, antifungal activity, and the evolving perspective of their clinical use.
Dimitrios I, Zonios, John E, Bennett
openaire   +2 more sources